|
EP1728514A1
|
|
Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation
|
|
IL165466D0
|
|
Immunostimulatory oligonucleotides and uses thereof
|
|
EP1657307A1
|
|
Oligonucleotides that induce the secretion of GM-CSF
|
|
EP1642585A1
|
|
Osteogenic oligonucleotides and uses thereof
|
|
CA2487904A1
|
|
Immunostimulatory oligonucleotides and uses thereof
|
|
CA2388049A1
|
|
Immunostimulatory oligonucleotides and uses thereof
|
|
FR2818254A1
|
|
PACKAGING FOR PHOTOSENSITIVE COLORANTS
|
|
FR2813891A1
|
|
MULTIFUNCTIONAL REAGENT FOR ERYTHROCYTES INVOLVING CARBAMATES AND APPLICATIONS
|
|
FR2783326A1
|
|
METHOD FOR THE DETECTION OR QUANTIFICATION OF BASOPHILES AND EOSINOPHILES
|
|
FR2781055A1
|
|
REAGENT AND METHOD FOR PERMEABILIZATION AND IDENTIFICATION OF ERYTHROCYTES
|
|
FR2778413A1
|
|
NOVEL REAGENTS AND METHOD FOR LYSIS OF ERYTHROCYTES
|
|
FR2773489A1
|
|
NEW COMPOSITION FOR THE OROMUCOUS ROUTE, ESPECIALLY PERNASAL
|
|
FR2768519A1
|
|
CALIBRATION METHOD OF A LIGAND - ANTI LIGAND TYPE DOSING SYSTEM
|
|
EP0786664A1
|
|
Diagnosis of opportunistic infections in aids patients
|
|
FR2743891A1
|
|
METHOD FOR THE IDENTIFICATION OR IMMUNOASSAY OF POLYPEPTIDE ANTIGENS
|
|
FR2732115A1
|
|
IMMUNOLOGICAL ASSAY PROCESS FOR CORTISOL, ESPECIALLY URINARY, AND REAGENTS USED
|
|
CA2128364A1
|
|
Anti-protein mediator therapeutic kits, a preparation method and pharmaceutical compositions containing them
|
|
FR2707882A1
|
|
New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
|
|
FR2705359A1
|
|
Method for protecting leukocyte cells, protective composition, protected blood composition, and blood analysis method.
|
|
FR2705360A1
|
|
Method and composition for erythrocyte lysis, blood composition, and leukocyte analysis method.
|
